

PLANT RESEARCH BREIFING PAPERS - Eight ASPP Members Testify Before Senate Agriculture Committee on Benefits Plant Biotechnology Will Bring to Farmers and Consumers
In
a hearing of the Senate Committee
on Agriculture, Nutrition and Forestry
held October 6, testimony on the benefits
of research using biotechnology was
presented by ASPP members Brian Larkins,
Bob Buchanan, Charles Arntzen, Ralph
Hardy, John Ohlrogge, Ray Bressan,
Dean DellaPenna, and Roger Beachy.
Dr.
Hardy, President of the National Agricultural
Biotechnology Council, provided an overview
of several issues that are pertinent
to the public debate on modified foods.
"Genetic
improvement of microorganisms, plants
and animals using molecular approaches
that are variously identified as genetically
engineered organisms, transgenic organisms
or genetically modified organisms, or
molecularly modified organisms have
received and continue to receive extensive
scientific examination regarding risks
to the environment and to humans. These
risks must be evaluated relative to
those of existing products that they
would replace. Genetically engineered
crops are inherently less risky because
of the ability to better ask and answer
the important risk questions than for
existing processes," Hardy said.
Dr.
Charles Arntzen, President and CEO of
the Boyce Thompson Institute for Plant
Research, and past ASPP Education Foundation
Board member, testified that there are
a number of new plant products that
are being created using recombinant
DNA technology that will directly benefit
human health here and particularly in
the developing world. "The next generation
of (biotech) products will increasingly
have direct value-added benefits for
food consumers as well as the indirect
value of protecting the environment,"
Arntzen noted. Dr. Arntzen's research
using biotechnology is leading to plants
engineered to be edible vaccines that
would prevent illnesses deadly to millions
of people.
Dr.
Brian Larkins of the University of Arizona
and ASPP Immediate Past President, explained
his research which is leading to high
quality protein corn. He noted that
enhanced corn in the diet could help
prevent and reverse several human maladies.
"Typically,
the protein in corn seeds contains around
two percent lysine, while we require
five percent lysine in our diet to avoid
protein deficiency disorders. Globally,
nearly 195 million children younger
than five years are undernourished for
protein, and in 1992, an estimated 12
million American children were estimated
to have diets that were significantly
lower in protein than what is recommended
by the National Academy of Sciences,"
Larkins said.
Dr.
Bob Buchanan of the University of California,
Berkeley, and ASPP Past President, said
that his in vitro studies on thioredoxin
using biotechnology have demonstrated
that thioredoxin: alleviates food and
pollen allergies; enhances the digestibility
and nutritional quality of foods; improves
the baking quality of poor quality flour;
and disarms neurotoxins of snakes scorpions
and bees. In addition to eliminating
allergens from wheat food products in
the lab, Buchanan has developed an animal
model to provide the first allergy test
for genetically modified foods.
Michigan
State University Professor Dr. John
Ohlrogge said that phase two of plant
genetic engineering presents the opportunity
to offer farmers new, high-value cash
crops leading to increased revenues.
Ohlrogge said his lab is working closely
with industrial chemists to develop
plants to produce feedstocks for new
types of polyurethanes, nylon with stronger
and more flexible fibers and biodegradable
lubricants
Dr.
Dean DellaPenna of the University of
Nevada at Reno, said that plant foods
can, in theory, provide almost all the
micronutrients essential for human nutrition,
however, in practice, most plant foods
(especially staple food crops) do not
contain the full complement of vitamins
or minerals in sufficiently concentrated
amounts to meet the recommended daily
allowance (RDA). He said research using
plant genomics and biotechnology could
lead to plants which would, in practice,
provide humans with needed levels of
micronutrients. These enhanced food
plants would offer dramatic benefits
for human health.
Dr.
Roger Beachy, President of the Donald
Danforth Plant Science Center, said
that the vast majority of plant and
agricultural scientists familiar with
how crops have been developed through
the years and the processes through
which those foods have been evaluated,
are amazed by the response of those
that seemingly do not want the technology
to be adopted. He cited comparative
risks in organic farming in which, unless
animal manure used to fertilize crops
are properly composted, it is a very
real source of E. coli contamination
on organically grown fruits and vegetables.
Senate
Agriculture Committee Chairman Richard
Lugar (R-IN) said, "There has been an
outcry against biotechnology in agriculture
among some sectors of European society
to the extent that the current approval
process in the European Union has virtually
ground to a halt," Chairman Lugar said.
He has been a strong supporter of use
of modern technologies in agriculture,
such as biotechnology.
Chairman
Lugar, Ranking Democrat Tom Harkin of
Iowa, Senator Thad Cochran (R-MS), Senator
Bob Kerrey (D-NE), Senator Charles Grassley
(R-IA) and Senator Peter Fitzgerald
(R-IL) engaged the plant scientist witnesses
with many questions and comments. The
majority of the Senators appeared supportive
of research using biotechnology.
However,
Sen. Kerrey expressed some disappointment
with some market rejections of modified
foods. He said that when he was in the
restaurant business, if the customers
did not order a particular menu item,
he believed he was being sent a message
that the particular rejected food item
on the menu was "garbage" and should
be taken off the menu.
Many
representatives from the media, life
science companies, producer and refiner
groups and others attended the hearing.
The large number of people attending
the hearing was sizeable enough to spill
out of the hearing room and into an
overflow room with internal televised
coverage of the hearing.
The
Senate Agriculture Committee held a
follow-up hearing October 7 with representatives
from USDA, EPA, FDA, Consumers Union,
the National Academy of Sciences, and
farm producer and refiner groups. Chairman
Lugar cited information presented October
6 by ASPP member scientists on several
occasions as he conducted the hearing
held the following day. The Committee
video taped the October 6 hearing with
testimony from eight ASPP member scientists
for further use on this issue.
From
the Committee Chair, to the Committee
staff to people in attendance, we heard
comments on the good preparation the
plant scientists' statements reflected.
The
hearing provided an influential audience
of policy makers and attending media
convincing examples of the value offered
by research using modern transformation
technologies. Members of the Committee
and attending media heard credible accounts
on the comparable safety of food products
developed with research using biotechnology.
They also heard of the value-added foods
and renewable energy sources that will
be coming with the next generation of
biotech products. Hearings like this
provide important facts needed by supporters
in the Congress to help fend off anti-biotech
proposals that are not based in science.
The testimony and responses to questions
by ASPP members also cited the value
of Congressional support for basic plant
research.
The
contribution by ASPP members in this
debate on modified foods before Congressional
Committees October 5 and 6 (see related
story on October 5 hearing) occurred
at a key time when some members of Congress
are considering seeking new restrictions
on biotech foods as a result of attempts
by anti-biotech groups to scare the
populace. By discussing research leading
to value-added foods that could provide
enhanced nutrition for consumers and
increased revenues for farmers, the
testimony provided many significant
reasons for continued support of modified
foods and research using biotechnology.